Showing results (661-670 of 735) with videos related to

Sort By:
Pageof 74
Nature|April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolutionChristopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Science (New York, N.Y.)|March 5, 2016
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, et al.
Nature Medicine|January 13, 2025
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinomaJames R M Black, Gabor Bartha, Charles W Abbott, et al.
Nature Cell Biology|December 31, 2024
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signallingWei-Ting Lu, Lykourgos-Panagiotis Zalmas, Chris Bailey, et al.
Nature Biotechnology|June 13, 2022
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progressionShaolong Cao, Jennifer R Wang, Shuangxi Ji, et al.
Nature Genetics|September 10, 2025
DNA methylation cooperates with genomic alterations during non-small cell lung cancer evolutionFrancisco Gimeno-Valiente, Carla Castignani, Elizabeth Larose Cadieux, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 2021
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced MelanomaJedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
The New England Journal of Medicine|September 29, 2019
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaJames Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
The New England Journal of Medicine|October 22, 2025
Nivolumab for Resected Stage III or IV Melanoma at 9 YearsPaolo A Ascierto, Michele Del Vecchio, Barbara Merelli, et al.
Pageof 74